ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

STXS vs OM // EV/EBITDA & P/E VALUATION

Stereotaxis Inc. (NYSE) VS. Outset Medical Inc. (NASDAQ) • 15-METRIC TALLY: STXS 3 — OM 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STXS VS. OM) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC STXS OM SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 52.70% 39.10% +13.60 STXS /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -28.00% -7.00 OM /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -15.01% — — TIE /fcf-yield <GO>
Operating Margin -60.00% -55.80% -4.20 OM /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 20.30% 5.10% +15.20 STXS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 6/9 -1.00 OM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 29.1 51.8 -22.69 OM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $91.2M $78.8M $12.4M STXS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR STXS REV OM REV STXS GROSS % OM GROSS % STXS FCF OM FCF
FY 2025 $32.4M $119.5M 52.7% 39.1% -$13.7M -$47.1M
FY 2024 $26.9M $113.7M 54.2% 33.9% -$8.5M -$117.2M
FY 2023 $26.8M $130.4M — — -$9.1M -$131.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STXS // BETA —
OM // BETA —